Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q3 2025 Earnings Call Transcript

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q3 2025 Earnings Call Transcript November 4, 2025

Amicus Therapeutics, Inc. misses on earnings expectations. Reported EPS is $0.06 EPS, expectations were $0.12.

Operator: Good morning, ladies and gentlemen, and welcome to the Amicus Therapeutics Third Quarter 2025 Financial Results Conference Call and webcast. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host, Mr....